Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke A Phase 1/2a Study

导出原文传递

翻译打印收藏纠错

作者： Steinberg, Gary K. ^[1] ; Kondziolka, Douglas ^[2] ; Wechsler, Lawrence R. ^[3] ; Lunsford, L. Dade ^[4] ; Coburn, Maria L. ^[5] ; Billigen, Julia B. ^[6] ; Kim, Anthony S. ^[7] ; Johnson, Jeremiah N. ^[8] ; Bates, Damien ; King, Bill ; Case, Casey ; McGrogan, Michael ; Yankee, Ernest W. ; Schwartz, Neil E.

作者单位： Western Stat Consulting LLC, Phoenix, AZ USA ^[1] NYU, Dept Neurosurg, New York, NY 10003 USA ^[2] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA ^[3] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA ^[4] Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,Rm R281, Stanford, CA 94305 USA ^[5] SanBio Inc, Mountain View, CA USA ^[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA ^[7] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA ^[8]

关键词 allogeneic transplantation mesenchymal stromal cells Notch 1 phase 1 clinical trial stem cells stereotactic techniques stroke

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交